Further tests are needed but a trial showed that, when compared against placebo treatment, those given the drug had a 79% lower risk of developing severe disease.
A promising new approach to treating MS tricks defective immune cells into thinking they are attacking the body, when they are in fact being attacked themselves.
Biological research can inspire technological innovation. Also, software that models computer networks can inform health care for patients with neurological disorders.
Trevor Kilpatrick, Florey Institute of Neuroscience and Mental Health
Young women are disproportionately affected by multiple sclerosis, a disease where the body attacks the brain, scrambling communication to the rest of the body. Here’s what we know about the causes.
All multiple sclerosis sufferers have stem cells with the potential to heal them, but scientists are only just figuring out how to kick them into action.
Gabrielle Belz, WEHI (Walter and Eliza Hall Institute of Medical Research) dan Cyril Seillet, WEHI (Walter and Eliza Hall Institute of Medical Research)
Women have evolved to have stronger immunity than men. But this comes with downsides -
women are more likely to have autoimmune diseases due to their “reactive” immune systems.
Fingolimod is a drug used to treat multiple sclerosis (MS), an autoimmune disease. It is an immunomodulator, which means it works by suppressing the immune system.
Before the last round of negotiations, only a handful of issues remained in the way of concluding the TPP. A potential deal-breaker for Australia was intellectual property protections for biologics.
Professor- Departments of Medical Microbiology & Immunology and Dermatology | Member- Foods For Health Institute | Member- Comprehensive Cancer Center | Director- Autoimmunity | Director- Immune Monitoring, University of California, Davis